This Article Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by FRASIER, S. D. Articles by LIPPE, B. M. Search for Related Content PubMed PubMed Citation Articles by FRASIER, S. D. Articles by LIPPE, B. M.

The Rational Use of Growth Hormone During Childhood

Division of Endocrinology, Department of Pediatrics, University of California at Los Angeles Los Angeles, California 90024
Department of Pediatrics, Olive View Medical Center, Sylmar, California 91342

Address requests for reprints to: S. Douglas Frasier, M.D., Department of Pediatrics, Room 3A-108, Olive View Medical Center, 14445 Olive View Drive, Sylmar, California 91342.

The virtually unlimited availability of hGH manufactured by recombinant DNA technology raises a number of difficult questions with regard to the rational use of this material in the management of short stature in childhood. The theoretical limits of such use range from the restriction of GH therapy to patients with classical GH deficiency, with the goal of achieving genetic growth potential, to providing GH for any child whose height is more than 2 SD below the mean for age regardless of etiology, with the goal of improving on genetic growth potential. This analysis will attempt to locate and hold a position somewhere between these two extreme poles. Our citations in this review are limited to recent studies employing recombinant hGH (rhGH). We will begin on solid ground and move across less firm terrain hoping to stop before losing our footing altogether.

Received February 2, 1990.

This article has been cited by other articles:

				B. S. Finkelstein, T. F. Imperiale, T. Speroff, U. Marrero, D. J. Radcliffe, and L. Cuttler Effect of Growth Hormone Therapy on Height in Children With Idiopathic Short Stature: A Meta-analysis Arch Pediatr Adolesc Med, March 1, 2002; 156(3): 230 - 240. [Abstract] [Full Text] [PDF]

				L. Cuttler, J. B. Silvers, J. Singh, U. Marrero, B. Finkelstein, G. Tannin, and D. Neuhauser Short Stature and Growth Hormone Therapy: A National Study of Physician Recommendation Patterns JAMA, August 21, 1996; 276(7): 531 - 537. [Abstract] [PDF]